Dolomite Bio decides to transfer µencapsulator system to Dolomite Microfluidics

Dolomite Bio has decided to transfer the µencapsulator system to their sister brand, Dolomite Microfluidics – an expert in microfluidic technology. This decision enables Dolomite Bio to have an enhanced commercial focus on their newest product range – the Nadia Product family.

The µencapsulator system will now be available from the Dolomite Microfluidic website, along with the full product information and literature.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dolomite Microfluidics. (2019, June 20). Dolomite Bio decides to transfer µencapsulator system to Dolomite Microfluidics. News-Medical. Retrieved on September 21, 2019 from https://www.news-medical.net/news/20190314/Dolomite-Bio-decides-to-transfer-c2b5encapsulator-system-to-Dolomite-Microfluidics.aspx.

  • MLA

    Dolomite Microfluidics. "Dolomite Bio decides to transfer µencapsulator system to Dolomite Microfluidics". News-Medical. 21 September 2019. <https://www.news-medical.net/news/20190314/Dolomite-Bio-decides-to-transfer-c2b5encapsulator-system-to-Dolomite-Microfluidics.aspx>.

  • Chicago

    Dolomite Microfluidics. "Dolomite Bio decides to transfer µencapsulator system to Dolomite Microfluidics". News-Medical. https://www.news-medical.net/news/20190314/Dolomite-Bio-decides-to-transfer-c2b5encapsulator-system-to-Dolomite-Microfluidics.aspx. (accessed September 21, 2019).

  • Harvard

    Dolomite Microfluidics. 2019. Dolomite Bio decides to transfer µencapsulator system to Dolomite Microfluidics. News-Medical, viewed 21 September 2019, https://www.news-medical.net/news/20190314/Dolomite-Bio-decides-to-transfer-c2b5encapsulator-system-to-Dolomite-Microfluidics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post